The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of immunoglobulin heavy chain variable region mutational status on the outcome of patients with chronic lymphocytic leukemia harboring isolated 13q deletion.
Gelenis C. Domingo
No relevant relationships to disclose
Samir Dalia
No relevant relationships to disclose
Julio C. Chavez
No relevant relationships to disclose
Estrella M. Carballido
No relevant relationships to disclose
Paibel I. Aguayo-Hiraldo
No relevant relationships to disclose
Kendra Lynn Sweet
No relevant relationships to disclose
Robert M. Crescentini
No relevant relationships to disclose
Lubomir Sokol
No relevant relationships to disclose
Jennifer L. Cultrera
No relevant relationships to disclose
Bijal D. Shah
No relevant relationships to disclose
Jeffrey E. Lancet
No relevant relationships to disclose
Eduardo M. Sotomayor
No relevant relationships to disclose
Rami S. Komrokji
No relevant relationships to disclose
Javier Pinilla-Ibarz
No relevant relationships to disclose